I agree that this site is using cookies. You can find further informations here.
X
Chamorro-de-Vega, Esther
28  results:
Search for persons X
?
1

Perceived quality of life by patients with immune-mediated ..:

Chamorro-de-Vega, Esther ; Calvo, Alberto ; Fernández-Pacheco, María...
Farmacia Hospitalaria.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

Remdesivir and SARS-CoV-2 monoclonal antibodies to prevent ..:

Vicente-Valor, Juan ; Rodríguez-González, Carmen ; Ferris-Villanueva, María...
Pharmacological Reports.  75 (2023)  5 - p. 1254-1264 , 2023
Link: https://doi.org/10.1007/..
 
?
3

Design and implementation of a mobile app for the pharmacot..:

Romero-Jimenez, Rosa ; Escudero-Vilaplana, Vicente ; Chamorro-de-Vega, Esther...
Frontiers in Immunology.  13 (2022)  - p. , 2022
Link: https://doi.org/10.3389/..
 
?
4

Dolutegravir-Based Dual Therapies in HIV Pretreated Patient..:

Amor-García, Miguel Ángel ; Rodríguez-González, Carmen Guadalupe ; Chamorro-de-Vega, Esther..
Annals of Pharmacotherapy.  56 (2021)  4 - p. 401-411 , 2021
Link: https://doi.org/10.1177/..
 
?
5

COVID-19 in hospitalised patients in Spain: a cohort study ..:

Rodriguez-Gonzalez, Carmen Guadalupe ; Chamorro-de-Vega, Esther ; Valerio, Maricela...
International Journal of Antimicrobial Agents.  57 (2021)  2 - p. 106249 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Etiology and Prognosis of Pneumonia in Patients with Solid ..:

Fernández-Cruz, Ana ; Ortega, Laura ; García, Gonzalo...
The Oncologist.  25 (2020)  5 - p. e861-e869 , 2020
Link: https://doi.org/10.1634/..
 
?
7

Effectiveness, Safety, and Costs of Dolutegravir/Abacavir/L..:

Rodriguez-Gonzalez, Carmen Guadalupe ; Chamorro-de-Vega, Esther ; Ortega-Navarro, Cristina...
Annals of Pharmacotherapy.  54 (2020)  7 - p. 633-643 , 2020
Link: https://doi.org/10.1177/..
 
?
8

A retrospective cohort of invasive fusariosis in the era of..:

Muñoz, Patricia ; Díez-Martín, José Luis ; Sánchez-Carrillo, Carlos...
Medical Mycology.  58 (2019)  3 - p. 300-309 , 2019
Link: https://doi.org/10.1093/..
 
?
9

Sofosbuvir/ledipasvir as treatment of hepatitis C virus gen..:

Chamorro-de-Vega, Esther ; Gimenez-Manzorro, Alvaro ; Sanjurjo, Maria
Medicina Clínica (English Edition).  151 (2018)  2 - p. 85-86 , 2018
Link: https://doi.org/10.1016/..
 
?
10

Improving pharmacotherapy outcomes in patients with hepatit..:

Chamorro-de-Vega, Esther ; Rodriguez-Gonzalez, Carmen Guadalupe ; Gimenez-Manzorro, Alvaro...
International Journal of Clinical Practice.  71 (2017)  8 - p. e12988 , 2017
Link: https://doi.org/10.1111/..
 
?
11

Effectiveness, Safety, and Costs of a Treatment Switch to D..:

Revuelta-Herrero, José Luis ; Chamorro-de-Vega, Esther ; Rodríguez-González, Carmen Guadalupe...
Annals of Pharmacotherapy.  52 (2017)  1 - p. 11-18 , 2017
Link: https://doi.org/10.1177/..
 
?
12

Switching to a rilpivirine/emtricitabine/tenofovir single-t..:

Arrabal-Durán, Paula ; Rodríguez-González, Carmen G ; Chamorro-de-Vega, Esther...
International Journal of Clinical Practice.  71 (2017)  8 - p. e12968 , 2017
Link: https://doi.org/10.1111/..
 
?
13

Treatment of refractory Candida krusei vaginitis with topic..:

Chamorro-de-Vega, Esther ; Gil-Navarro, Maria-Victoria ; Perez-Blanco, Jose-Luis
Medicina Clínica (English Edition).  147 (2016)  12 - p. 565-566 , 2016
Link: https://doi.org/10.1016/..
 
?
14

Effectiveness and Safety of Ombitasvir-Paritaprevir/Ritonav..:

Chamorro-de-Vega, Esther ; Gimenez-Manzorro, Alvaro ; Rodriguez-Gonzalez, Carmen Guadalupe...
Annals of Pharmacotherapy.  50 (2016)  11 - p. 901-908 , 2016
Link: https://doi.org/10.1177/..
 
?
15

Design and implementation of a mobile app for the pharmacot..:

Romero-Jimenez, Rosa ; Escudero-Vilaplana, Vicente ; Chamorro-de-Vega, Esther...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9367980/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15